login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
THE NIGHTVIEW FUND (NITE) Stock News
NYSEARCA:NITE - NYSE Arca -
US14064D4850
-
ETF
- Currency: USD
31.2215
-0.84 (-2.61%)
Summary
Stock Chart
Technical Analysis
News
NITE Latest News, Press Relases and Analysis
All
Press Releases
8 days ago - By: Benzinga
- Mentions:
VCR
TSLA
TESL
Tesla's Earnings Flop Trips Up These ETFs
3 months ago - By: Benzinga
- Mentions:
VCR
XLY
TSLA
TESL
Tesla's Energy Division Shines, But ETF Risks Mount Amid Broader Challenges
6 years ago - By: Bloomberg
- Mentions:
BIIB
GILD
BMY
CELG
...
Biogen Leads List of Drugmakers Left to Make a Needed M&A Splash
6 years ago - By: Bloomberg
- Mentions:
QURE
BIIB
Gene-Therapy Firm UniQure Explores Options Including Sale
6 years ago - By: Seeking Alpha
- Mentions:
BIIB
BIIB
Biogen completes Nightstar buy
6 years ago - By: Seeking Alpha
- Mentions:
BIIB
BIIB
Biogen acquires Nightstar for $800M
6 years ago - By: Investor's Business Daily
- Mentions:
JNJ
MGTX
AGTC
BIIB
Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout
6 years ago - By: Monteverde & Associates PC
- Mentions:
GTXI
BPI
COTY
CTL
...
INVESTOR ALERT: Monteverde & Associates PC is Investigating the Recently Announced Acquisition
6 years ago - By: Investor's Business Daily
- Mentions:
BMY
CELG
GSK
TAK
...
Celgene Stock Breaks Out As Bristol Grabs Key Merger Endorsement
6 years ago - By: InvestorPlace
- Mentions:
AMGN
GILD
Biogen Stock Fell Too Far on Unfortunate News
6 years ago - By: Investor's Business Daily
- Mentions:
IBB
BIIB
BMY
IONS
...
Biogen Crashes On Alzheimer's Flop — Is Its Remaining Pipeline A Dud?
6 years ago - By: TalkMarkets
- Mentions:
XLV
IBB
FBT
SPY
...
Sideways Market Vexes Traders: Biotech Stocks are Fading
6 years ago - By: Investor's Business Daily
- Mentions:
BIIB
How Much Does Biogen Gain From Its $800 Million Gene Therapy Buyout?
Please enable JavaScript to continue using this application.
